Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B

✍ Scribed by P. Lampertico; A. Marzano; M. Levrero; T. Santantonio; V. Di Marco; M. Brunetto; P. Andreone; E. Sagnelli; S. Fagiuoli; G. Mazzella; G. Raimondo; G.B. Gaeta; A. Ascione

• Book ID: 119228479
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 55 KB
• Volume: 39
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/j.dld.2006.12.036